Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
94.45
-4.01 (-4.07%)
At close: Oct 2, 2026, 4:00 PM EDT
94.72
+0.27 (0.29%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $5.92 billion as of October 2, 2026. Its market cap has increased by 611.61% in one year.
Market Cap
5.92B
Enterprise Value
5.85B
1-Year Change
611.61%
Ranking
Category
Stock Price
$94.45
ChartMarket Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $359.30M to $5.92B, an increase of 1,548.81%. That is a compound annual growth rate of 41.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 5.92B | 299.42% |
| Dec 31, 2025 | 1.48B | 183.27% |
| Dec 31, 2024 | 523.60M | 228.28% |
| Dec 29, 2023 | 159.50M | -57.41% |
| Dec 30, 2022 | 374.50M | -91.46% |
| Dec 31, 2021 | 4.38B | -33.39% |
| Dec 31, 2020 | 6.58B | 146.86% |
| Dec 31, 2019 | 2.67B | 919.62% |
| Dec 31, 2018 | 261.50M | -27.22% |
| Oct 4, 2018 | 359.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 6.98B |
| Belite Bio | 6.76B |
| Iovance Biotherapeutics | 6.62B |
| Rhythm Pharmaceuticals | 6.57B |
| CG Oncology | 6.17B |
| Ligand Pharmaceuticals | 6.14B |
| Scholar Rock Holding | 5.83B |
| Oruka Therapeutics | 5.54B |